Increased expression of CCN1 might promote angiogenesis, deregulated proliferation, enhanced cell survival and tumor invasiveness, and chemoresistance in breast cancer cells by activating integrin αvβ3-driven cellular signaling [14, 17, 30, 41]. This evidence concerns the gene CCN1 and breast carcinoma.